• Biopharma & Diagnostics

  • Helping You Capitalize on Emerging Trends

    Biopharma is a sector of stark contrasts. The excitement over the prospects for personalized medicine and new orphan drugs receiving accelerated approval is in tension with industry-wide anxiety over increasingly stringent regulations and unproven business models. Without a financial partner to provide clarity, support and strategic relationships, a company could miss out on opportunities to succeed in this rapidly evolving industry.   

    Silicon Valley Bank (SVB) understands the financial and regulatory dynamics of this unique and complex sector and empowers biopharma companies with industry knowledge and robust banking solutions to mitigate risks and grow their business. We offer growing later-stage companies additional capital to transform their business and earlier stage companies extended runways to buy extra time during prolonged development cycles.

    SVB Analytics' proprietary data provides clients with more accurate sector insights and forecasts than they would get anywhere else; as an example, our industry reports were among the first to contradict the widely-held perception that limited returns in the sector would reduce overall funding and M&A upfront payouts.

    Connecting Your Company to a Network of Relationships

    If you're looking for potential customers, partners, acquisitions, or investors to grow your business, SVB's deep connections with industry influencers include large healthcare providers, big pharma, growing companies, promising startups, and the top-tier investors who are active in your space.

    SVB offers clients unparalleled customer service supported by a complete suite of banking solutions and advisory services that include:  

    • Credit Solutions

      Range of credit solutions from large syndicated deals to asset-based and cash-flow lending to venture debt.
    • Treasury Management

      Global cash management products streamline receivables and payables cycles for secure access to operating cash. Our investment solutions — such as sweep accounts, money market mutual funds and sophisticated managed accounts — are customized to meet your investment horizon, from operating cash to strategic cash offered by our fiduciary asset management team.
    • International Solutions

      Tailored services and solutions, including letters of credit, trade finance, FX solutions, and Export-Import (EXIM) Bank financing, to enable international growth and hedge currency risk to ensure a competitive advantage.
    • SVB Analytics

      SVB Analytics' proprietary data translates to deep insights and fact-based growth forecasts that make sense of macroeconomic trends, and ensure more accurate company valuations.
    • Startup Resources

      SVB's Accelerator Bundle offers all the banking products startups need — at preferred pricing. Mentorship provided to companies through our network of relationships with several top incubator groups and introductions to acquiring companies, reputable funds, and potential strategic partners.

    Contact us to learn why more biopharma companies are relying on Silicon Valley Bank for banking solutions to help navigate their industry.

  • Select Clients

  • *Disclaimer: Money market mutual funds are offered by SVB Securities, a wholly owned broker-dealer subsidiary, member FINRA/SIPC. Managed accounts are offered by SVB Asset Management a non-bank affiliate of Silicon Valley Bank and registered investment advisor. Products offered by SVB Securities and SVB Asset Management are not FDIC insured, are not deposits or other obligations of Silicon Valley Bank, and may lose value. Sweep accounts are offered by Silicon Valley Bank.